The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot.In this case, there was no reported device malfunction associated with the steerable guide catheter (sgc).The reported patient effects of atrial perforation and respiratory distress as listed in the are known possible complications associated with mitraclip procedures.Based on the information reviewed, there is no indication of a product issue with respect to manufacture, design or labeling.The mitraclip referenced is filed under a separate medwatch report number.
|
Patient id: (b)(6).This report is filed due to a clinically significant atrial septal defect.It was reported that on (b)(6) 2020, the patient presented with degenerative mitral regurgitation (mr) grade 4+, a posterior leaflet prolapse and flail.Two mitraclips (cds0701-xtw, 91021u117 and 91021u121) were implanted without a device issue, reducing the mr to grade 1+-2+.On (b)(6) 2020, at the time of discharge the patient became hypoxic on exertion.Prolonged hospitalization was required.On (b)(6) 2020, per imaging, the mr had increased to grade 4+.The clips had remained stable, however, secondary chordae of the p2 leaflets, attached to the most lateral clip, had ruptured.Reportedly, it is unknown which implanted clip had the associated ruptured chordae.A residual bidirectional iatrogenic atrial shunt was also observed.As treatment, another mitraclip was implanted, reducing the mr to mild, and an atrial septal defect (asd) occluder was placed.The event resolved without sequela.No additional information was provided regarding this issue.
|